Factors Involved in Anti-VEGF Treatment Decisions for Neovascular Age-Related Macular Degeneration: Insights from Real-World Clinical Practice.

Glenn Yiu Shilpa Gulati Victoria S Higgins Emily Coak Daniel Mascia Eunice KimGalin SpicerDavid Tabano

Published in: Clinical ophthalmology (Auckland, N.Z.) (2024)

Physicians face barriers to prescribing their preferred anti-VEGF agents in real-world healthcare settings. Overcoming these challenges may improve treatment outcomes for patients with nAMD.

Keyphrases

age related macular degeneration
primary care
vascular endothelial growth factor
healthcare
clinical practice
endothelial cells
adverse drug
drug induced